Company: CWAN
Filing Date: 2025-02-11
Form Type: S-4
Source: 0001193125-25-023759
Chunk: 193

Company: Clearwater Analytics Holdings, Inc.
Filing Date: 2025-02-11
Form: S-4
Chunk 193
---
 or                                                                           
 its subsidiaries that could reasonably be expected to prevent the Corporate Mergers, taken together, from qualifying as a reorganization within the meaning of Section 368(a) of the Code; |

| • |     | employee benefit plans; |

| • |     | labor and employment matters; |

| • |     | insurance matters; |

| • |     | environmental matters; |

| • |     | trademarks, patents, copyrights and other intellectual property matters; |

| • |     | information technology systems; |

| • |     | artificial intelligence systems; |

| • |     | real property leased or subleased by Enfusion and its subsidiaries; |

| • |     | data security and privacy matters; |

| • |     | payment of fees to brokers in connection with the Merger Agreement; |

| • |     | the rendering of Goldman Sachs’ fairness opinion to the Enfusion Board; |

| • |     | the inapplicability of anti-takeover statutes to the Merger Agreement, the Support Agreements, the Transactions 
 and the transactions contemplated thereby; and                                                                  |

| • |     | Enfusion and its subsidiaries’ absence of ownership of any shares of capital stock of Clearwater. |

In the Merger Agreement, the Buyer Parties made customary representations and warranties to Enfusion that are subject, in some cases, to specified exceptions and qualifications contained in the Merger Agreement. These representations and warranties relate to, among other things:

| • |     | due organization, good standing and authority and qualification to conduct business with respect to the Buyer 
 Parties;                                                                                                      |

| • |     | the Buyer Parties’ authority to enter into and perform the Merger Agreement; |

| • |     | required consents and regulatory filings in connection with the Merger Agreement and performance thereof; |

122

| • |     | the absence of any conflict or violation of the Buyer Parties’ organizational documents, existing contracts,                                                                                  
 applicable law or order or the resulting creation of any lien upon the Buyer Parties’ properties or assets due to the execution and delivery of the Merger Agreement and performance thereof; |

| • |     | the capital structure and capitalization of Clearwater; |

| • |     | the capital structure of Acquirer, Merger Sub and Merger Sub II; |

| • |     | the absence of any required vote or approval of holders of voting interests in the Clearwater; |

| • |     | the absence of legal proceedings and orders; |

| • |